First results of Phase 3 Trial of RTS,S/AS01 malaria vaccine in African children
Submitted by susan on Mon, 2011-10-31 12:26
An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.
Main Topic:
Mark Content Private(Internal):
External URL:
http://www.nejm.org/doi/pdf/10.1056/NEJMoa1102287
Email Alert:
1-13
Publication Date:
18/10/2011